Peri-ovulatory putrescine supplementation reduces embryo resorption in older mice.

Abstract

STUDY QUESTION:

Does peri-ovulatory putrescine supplementation of older mice improve oocyte quality and reduce the incidence of embryo resorption?

SUMMARY ANSWER:

Peri-ovulatory putrescine supplementation in older mice improved oocyte quality, as indicated by increased blastocyst cell numbers and reduced the incidence of embryo resorption.

WHAT IS KNOWN ALREADY:

Rodents exhibit a transient rise of ornithine decarboxylase (ODC) and putrescine in the ovaries during ovulation. Older mice exhibit reduced ovarian ODC activity during ovulation. Supplementation of in vitro maturation medium with putrescine reduces oocyte aneuploidy rates of older mice.

STUDY DESIGN, SIZE, DURATION:

The rationale was to correct ovarian putrescine deficiency in older mice by peri-ovulatory putrescine supplementation in drinking water and to observe the reproductive consequences of this intervention. This project was conducted between 2010 and 2014.

PARTICIPANTS/MATERIALS, SETTING, METHODS:

Older mice (9-11 months of age) were given regular drinking water (control) or drinking water with 1% putrescine dihydrochloride (62 mM) for 2-4 days before mating. Plugged mice were then withdrawn from putrescine supplementation. Blastocysts were retrieved on 3.5 days post coitum (dpc) for the determination of cell numbers. For resorption analyses, mice were killed on 9.5 dp or 12.5 dpc, and implantation sites were dissected to determine the embryo status. For birth studies, mice were examined every morning between 16.5 and 23.5 dpc. Births were recorded as live or stillbirth.

MAIN RESULTS AND THE ROLE OF CHANCE:

We demonstrated that deficiency of ovarian putrescine in older mice can be restored by peri-ovulatory putrescine supplementation in drinking water. Putrescine supplementation in older mice increased blastocyst cell numbers (from 40 to 54; P < 0.0001, t-test), reduced embryo resorption rates (from 41.1 to 15.4% in old C57BL/6 mice, P < 0.0001, Fisher's exact test; from 14.2 to 6.4% in old CF1 mice, P = 0.004, Fisher's exact test), and doubled the number of live born pups. Furthermore, exogenous putrescine exhibited rapid absorption and excretion, and showed no toxicity to mothers or fetuses.

LIMITATIONS, REASONS FOR CAUTION:

The mechanism of putrescine action in oocytes and/or ovaries remains unclear.

WIDER IMPLICATIONS OF THE FINDINGS:

Peri-ovulatory putrescine deficiency in older mice appears to adversely impact on oocyte maturation resulting in poor quality embryos (as assessed by blastocyst cell numbers) and early embryo death. This study demonstrates a natural and simple remedy to improve oocyte quality in older women.

STUDY FUNDING/COMPETING INTERESTS:

This study was supported by the NSERC, the March of Dimes Foundation, and the National Natural Science Foundation of China. The authors declare no competing interest.

• Authors: Yong Tao, Dandan Liu, Guolong Mo, Hongmei Wang, X Johné Liu
• Journal: Human reproduction (Oxford, England) (Hum Reprod) Vol. 30 Issue 8 Pg. 1867-75 (Aug 2015) ISSN: 1460-2350 [Electronic] England
• PMID: 26082481 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
• Copyright: © The Author 2015. Published by Oxford University Press on behalf of the European Society of Human Reproduction and Embryology. All rights reserved. For Permissions, please email: [email protected].

Chemical References

• Putrescine

Topics

• Animals
• Embryo Loss (prevention & control)
• Female
• Mice
• Mice, Inbred C57BL
• Oocytes (drug effects)
• Ovulation (drug effects)
• Pregnancy
• Putrescine (pharmacology, therapeutic use)